The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference57 articles.
1. Four-week administration of nimesulide, a cyclo-oxygenase-2 inhibitor, improves endothelial dysfunction in the hindlimb vasculature of streptozotocin-induced diabetic rats;Abdelrahman;Arch. Pharm. Res.,2008
2. Cyclooxygenase inhibition and cardiovascular risk;Antman;Circulation,2005
3. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor;Bauersachs;Circulation,1996
4. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice;Brandes;Proc. Natl. Acad. Sci. USA,2000
5. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial;Bresalier;N. Engl. J. Med.,2005
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats;Biomedicine & Pharmacotherapy;2022-09
2. Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment;Journal of Pharmacological Sciences;2021-09
3. Blockade of 5‐HT2receptors with sarpogrelate uncovers 5‐HT7receptors inhibiting the tachycardic sympathetic drive in pithed rats;Clinical and Experimental Pharmacology and Physiology;2019-12-25
4. Serotonin and Cardiovascular Diseases;Serotonin;2019
5. Chronic 5-HT2 receptor blockade unmasks the role of 5-HT1F receptors in the inhibition of rat cardioaccelerator sympathetic outflow;Canadian Journal of Physiology and Pharmacology;2018-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3